Thoma Bravo completed a minority investment in Summa Equity-backed LOGEX.

Thoma Bravo, a private equity firm, completed a minority investment in Summa Equity-backed LOGEX, a healthcare analytics company. Financial terms were not disclosed. "Our mission is to turn data into better healthcare. There is an urgent need for stronger, more resilient, and more accessible health systems in Europe. We are already active in 10 European markets and we know we can play a meaningful role in evolving healthcare in Europe and making systems interoperable for improved international collaboration if we can expand further. Thoma Bravo, with their deep technical knowledge and their expertise in operational excellence, will be a fantastic partner to help us achieve that goal," Philipp Jan Flach, LOGEX CEO.